Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Boston Scientific Vercise Cartesia 16-contact Directional Lead (X/HX) With Deep Brain Stimulation (DBS) Systems for the Treatment of Parkinson's Disease (PD)

NCT04577651 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04577651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04577651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Boston Scientific Vercise Cartesia 16-contact Directional Lead (X/HX) With Deep Brain Stimulation (DBS) Systems for the Treatment of Parkinson's Disease (PD)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2020
Completion date
January 28, 2025
Enrollment
58 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease